Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension∗
- 30 June 1962
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 9 (6), 863-867
- https://doi.org/10.1016/0002-9149(62)90211-4
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINEAnnals of the New York Academy of Sciences, 1960
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- The action of reserpine on the peripheral sympathetic systemThe Journal of Physiology, 1958
- Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanineArchives of Biochemistry and Biophysics, 1954
- DopadecarboxylaseThe Science of Nature, 1939
- Fermentativer Abbau von l-Dioxyphenylalanin (Dopa) durch NiereNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1938